Status:

TERMINATED

Urodynamic Evaluation in Post-radiation Salvage Prostatectomy Patients

Lead Sponsor:

M.D. Anderson Cancer Center

Conditions:

Prostate Cancer

Eligibility:

MALE

Brief Summary

Objectives: The primary objective of this study is to determine whether bladder compliance is significantly lower in men who undergo prostatectomy for recurrence following primary radiation therapy t...

Detailed Description

Study Participation: You will come to the urology clinic for 1 visit. At this visit, a video urodynamics test will be performed. The urodynamics test is used to check bladder and urinary function usi...

Eligibility Criteria

Inclusion

  • Men who have undergone radical prostatectomy, via an open or minimally invasive approach, as primary treatment for a diagnosis of prostate cancer.
  • Men who have undergone salvage prostatectomy for recurrence after first-line radiation therapy for prostate cancer.
  • Men who underwent prostatectomy at least one year prior to study entry date. Men who received perioperative (or peri-XRT) chemotherapy or hormone therapy are eligible.

Exclusion

  • Men who underwent other primary or secondary treatments for prostate cancer--hormone therapy as only treatment, cryosurgery, adjuvant radiation after prostatectomy
  • Men with a history of neurogenic bladder, as demonstrated by previous urodynamics.
  • Men with a history of severe outlet obstruction due to longstanding benign prostatic hyperplasia. This will be demonstrated objectively by documentation in the patient's history of preoperative AUA symptom score greater than 15 or a history of urinary retention or nocturia greater than 2 episodes per night.
  • Men who underwent additional reconstructive procedures at the time of or subsequent to prostatectomy, including augmentation, urethral sling, or urinary diversion.

Key Trial Info

Start Date :

June 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2010

Estimated Enrollment :

2 Patients enrolled

Trial Details

Trial ID

NCT00901420

Start Date

June 1 2007

End Date

May 1 2010

Last Update

July 31 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UT MD Anderson Cancer Center

Houston, Texas, United States, 77030